Sublingual Dissolving Microneedle (SLDMN)-based Vaccine For Inducing Mucosal Immunity Against SARS-CoV-2
Description
The coronavirus pandemic accelerates the development of next-generation vaccination technology to combat future pandemic outbreaks. Mucosal vaccination effectively protects the mucosal surfaces, the primary sites of viral entry, by inducing the
